TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 61 filers reported holding TRANSLATE BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,018,000 | +63.3% | 145,901 | -2.2% | 0.00% | +100.0% |
| Q1 2021 | $2,460,000 | +11.9% | 149,194 | +25.0% | 0.00% | 0.0% |
| Q4 2020 | $2,199,000 | -55.3% | 119,380 | -67.0% | 0.00% | -66.7% |
| Q3 2020 | $4,919,000 | +862.6% | 361,478 | +1166.3% | 0.00% | – |
| Q2 2020 | $511,000 | +312.1% | 28,546 | +130.9% | 0.00% | – |
| Q1 2020 | $124,000 | +22.8% | 12,361 | -1.6% | 0.00% | – |
| Q4 2019 | $101,000 | +23.2% | 12,567 | +50.4% | 0.00% | – |
| Q3 2019 | $82,000 | -68.7% | 8,353 | -59.9% | 0.00% | – |
| Q2 2019 | $262,000 | -25.6% | 20,856 | -40.0% | 0.00% | – |
| Q1 2019 | $352,000 | +458.7% | 34,740 | +307.6% | 0.00% | – |
| Q4 2018 | $63,000 | -84.9% | 8,523 | -79.6% | 0.00% | – |
| Q3 2018 | $417,000 | – | 41,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |